LF
LFMD.US LifeMD Inc
- Market cap
- USD 106M
- P/E
- -
- P/B
- 9.99x
- ROE
- -
- Dividend yield
- 2.93%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is LFMD.US undervalued?
Graham numberThe Graham number of LifeMD Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LifeMD Inc fundamental analysis
No fundamental analysis for LifeMD Inc yet.
LifeMD Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and Shapi…
Full company profileLifeMD Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
LifeMD Inc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.24M | 5.05M | 8.32M | 12.5M | 37.3M | 92.9M | 119M | 153M | 212M | 194M | 189M |
| Gross Profit | 3.29M | 3.57M | 6.36M | 9.94M | 28.4M | 74.9M | 100M | 134M | 188M | 155M | 161M |
| Operating Income | -1.17M | -1.07M | -2.06M | -2.89M | -57.8M | -54.3M | -43.4M | -14.5M | -16.1M | -7.67M | -27.4M |
| EBITDA | -1.17M | -1.07M | -1.86M | -2.55M | -57.4M | -57.4M | -35.9M | -8.21M | -6.65M | -1.52M | -19.1M |
| Net Income | -1.11M | -1.21M | -1.24M | -3.14M | -60.5M | -60.9M | -45.5M | -20.6M | -18.9M | -7.11M | -27.2M |
| EPS | -0.16 | -0.14 | -0.14 | -0.32 | -4.24 | -2.25 | -1.47 | -0.61 | -0.46 | -0.16 | -0.57 |
| Balance Sheet | |||||||||||
| Total Assets | 790K | 1.26M | 2.62M | 3.45M | 13.4M | 49.9M | 25.7M | 58.5M | 72.5M | 70.4M | 66.3M |
| Total Liabilities | 1.15M | 641K | 1.80M | 4.58M | 14.2M | 24.1M | 33.0M | 52.9M | 76.5M | 47.3M | 66.9M |
| Shareholders' Equity | -355K | 882K | 898K | -988K | 1.35M | 26.9M | -6.83M | 3.51M | -5.49M | 23.2M | -580K |
| Cash & Short-term Investments | 183K | 141K | 180K | 1.11M | 9.18M | 41.3M | 3.96M | 33.1M | 35.0M | 36.8M | 21.9M |
| Total Debt | 206K | 167K | 247K | 845K | 1.06M | 1.85M | 4.13M | 18.9M | 25.1M | 6.32M | 5.85M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -408K | -817K | -906K | 251K | -12.1M | -33.1M | -22.9M | 8.82M | 17.5M | 8.28M | -9.91M |
| Capital Expenditure | 0.00 | 0.00 | 100K | 247K | 398K | 3.40M | 12.9M | 8.73M | 11.5M | 9.52M | 6.91M |
| Free Cash Flow | -408K | -817K | -1.01M | 251K | -12.5M | -36.5M | -35.8M | 86.9K | 5.98M | -1.24M | -16.8M |
| Ratios | |||||||||||
| ROE | - | -136.7% | -138.2% | - | -4,470.3% | -226.8% | - | -587.6% | - | -30.7% | - |
| ROA | -140.2% | -95.4% | -47.4% | -91.0% | -451.6% | -122.0% | -177.4% | -35.2% | -26.1% | -10.1% | -41.1% |
| Net Profit Margin | -21.1% | -23.9% | -14.9% | -25.2% | -162.3% | -65.6% | -38.3% | -13.5% | -8.9% | -3.7% | -14.4% |
| Debt to Equity | - | 0.19x | 0.28x | - | 0.79x | 0.07x | - | 5.40x | - | 0.27x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
LifeMD Inc dividends
- Dividend yield
- 2.93%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 3.11M | 0.07 | - |
| 2024 | USD 3.11M | 0.08 | - |
| 2023 | USD 3.11M | 0.09 | - |
| 2022 | USD 3.11M | 0.10 | - |
| 2021 | USD 871K | 0.03 | - |
| 2020 | USD 1.29M | 0.09 | - |
| 2019 | USD 871K | 0.09 | - |
| 2018 | USD 871K | 0.10 | - |
| 2017 | USD 879K | 0.10 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Oct 14, 2020.
Who owns LifeMD Inc
- Insiders 16.17%
- Institutions 42.21%
- Public & others 41.62%
- Shares outstanding 48.3M
- Free float 39.8M
Top funds holding LFMD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Federated Hermes MDT Small Cap Core IS | 2.09M | 4.49% | +46.70% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.22M | 2.63% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.02M | 2.19% | 0.00% | Oct 2026 |
| Federated Hermes MDT Small Cap Growth IS | 999K | 2.14% | +67.88% | Sep 2026 |
| Bridge Builder Small Cap Fund | 953K | 2.04% | +4.43% | Oct 2026 |
| Stt Strt®SPDR®S&PKenshoNwEcosComposETF | 529K | 1.13% | +0.08% | Oct 2026 |
| Fidelity Small Cap Index | 461K | 0.99% | +5.34% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 288K | 0.62% | -0.38% | Oct 2026 |
| Vanguard Russell 2000 ETF | 237K | 0.51% | +2.79% | Sep 2026 |
| Fidelity Extended Market Index | 203K | 0.44% | -8.66% | Sep 2026 |
| iShares Micro-Cap ETF | 123K | 0.26% | 0.00% | Oct 2026 |
| Schwab Small Cap Index | 93.1K | 0.20% | 0.00% | Sep 2026 |
| iShares Russell 2000 Value ETF | 82.2K | 0.18% | 0.00% | Oct 2026 |
| Fidelity Total Market Index | 75.0K | 0.16% | -0.05% | Sep 2026 |
| iShares Russell 2000 Small-Cap Idx Instl | 68.0K | 0.15% | -21.80% | Sep 2026 |
| Fidelity Series Total Market Index | 64.0K | 0.14% | 0.00% | Sep 2026 |
| iShares Core S&P Total US Stock Mkt ETF | 60.1K | 0.13% | +0.03% | Oct 2026 |
| Stt Strt SPDR® Russell2000 US SmCapETF | 55.0K | 0.12% | -5.92% | Oct 2026 |
| EA Bridgeway Ultra-Small Company Mkt ETF | 55.0K | 0.12% | 0.00% | Oct 2026 |
| Nuveen Small Cap Blend Idx R6 | 54.6K | 0.12% | 0.00% | Sep 2026 |
Top institutions holding LFMD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 3.03M | 6.29% | +8.03% | Jun 2026 |
| Federated Hermes Inc | 2.75M | 5.69% | +169.62% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.73M | 3.59% | +4.27% | Jun 2026 |
| State Street Corp | 1.32M | 2.73% | +22.63% | Jun 2026 |
| Geode Capital Management, LLC | 1.07M | 2.21% | +4.73% | Jun 2026 |
| Renaissance Technologies Corp | 991K | 2.05% | -8.23% | Sep 2026 |
| Prescott Group Capital Management LLC | 897K | 1.86% | +0.20% | Jun 2026 |
| BRC Group Holdings Inc | 637K | 1.32% | -26.88% | Jun 2026 |
| Royce & Associates, LP | 636K | 1.32% | -47.06% | Jun 2026 |
| AQR Capital Management LLC | 620K | 1.28% | +212.37% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 557K | 1.16% | +116.80% | Jun 2026 |
| Susquehanna International Group, LLP | 478K | 0.99% | +2.81% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 404K | 0.84% | +10.87% | Jun 2026 |
| Millennium Management LLC | 402K | 0.83% | 0.00% | Jun 2026 |
| Northern Trust Corp | 357K | 0.74% | +6.72% | Jun 2026 |
| Jacobs Levy Equity Management, Inc. | 335K | 0.70% | 0.00% | Jun 2026 |
| Walleye Trading Advisors, LLC | 324K | 0.67% | 0.00% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 284K | 0.59% | -1.72% | Jun 2026 |
| Tudor Investment Corp Et AL | 274K | 0.57% | 0.00% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 273K | 0.57% | +17.38% | Jun 2026 |
LifeMD Inc company profile
- Company name
- LifeMD Inc
- Ticker
- LFMD.US
- Exchange
- USA Stocks
- Listed since
- Jan 2, 2001
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 347
- Fiscal year end
- December
- Address
- 236 Fifth Avenue, New York, NY, United States, 10001
- Phone
- 866 351 5907
- Website
- lifemd.com
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
LifeMD Inc management
10- Mr. Justin SchreiberChairman & CEO · born 1983
- Ms. Shayna Webb DrayChief Operating Officer · born 1987
- Mr. Stefan GalluppiChief Innovation Officer · born 1987
- Mr. Atul KavthekarChief Financial Officer
- Ms. Maria E. Stan CPAChief Accounting Officer & Controller · born 1975
- Mr. Umesh SripadChief Technology Officer
- Mr. Eric H. YeciesChief Legal Officer, General Counsel & Corporate Secretary · born 1978
- Mr. Shane BiffarChief Compliance Officer & Deputy General Counsel · born 1983
- Mr. Chris PisanoChief Marketing Officer · born 1975
- Mr. Gerard Rotonda IIIManaging Director of Strategy & Business Development · born 1969